Nebenwirkungen · Mvasi
MVASI 25 mg/mL concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 22
HOS-140991 · Präparat HOS-098594
System organ class Reactions (frequency*) (SOC) Infections and infestations Necrotising fasciitis, usually secondary to wound healing complications, gastrointestinal perforation or fistula formation (rare) (see section 4.4) Immune system disorders Hypersensitivity reactions and infusion reactions (common); with the following possible co-manifestations: dyspnoea/difficulty breathing, flushing/redness/rash, hypotension or hypertension, oxygen desaturation, chest pain, rigors and nausea/vomiting (see section 4.4 and Hypersensitivity reactions (including anaphylactic shock)/infusion reactions above).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-08T12:03:00Z · SHA-256 7315a0f92d93f32ff51c381d8e3464645773cd3c5a1bc96a97e09c6d6939e82e · Passage 9be3ed92745abc0debd626084bcd25915ab250a549963047e468bbe3bf547a6b · Zeichen 40692–41587 im Abschnitt